NEW YORK — Spanish diagnostics firm Vitro has signed on Biocare Medical as the exclusive US distributor of its NeoPath Pro high-throughput laboratory testing instrument, the companies said this week.
Slated for launch later this month, NeoPath Pro has a 42-slide capacity and is used for advanced immunohistochemistry (IHC), in situ hybridization, and fluorescence in situ hybridization applications.
Financial and other terms of the distribution agreement were not disclosed.
Based in Pacheco, California, Biocare markets a range of cancer diagnostic tools including primary antibodies, antibody detection systems, and IHC instrumentation.